PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25323905-7	2014	Treatment of wild-type SK-OV-3 cells with the DNA methyltransferase inhibitor 5-aza-2"-deoxycytidine reduced methylation of the CA9 promoter and increased CA9 mRNA expression.	Decitabine	78-100	carbonic anhydrase 9	Homo sapiens	128-131	
25323905-7	2014	Treatment of wild-type SK-OV-3 cells with the DNA methyltransferase inhibitor 5-aza-2"-deoxycytidine reduced methylation of the CA9 promoter and increased CA9 mRNA expression.	Decitabine	78-100	carbonic anhydrase 9	Homo sapiens	155-158	
15951534-8	2005	In vitro analysis revealed that loss of Ca9 expression in gastric cancer cell lines was restored after treatment with 5"-azadeoxycytidine and was associated with increased invasion (p<0.01).	Decitabine	118-137	carbonic anhydrase 9	Homo sapiens	40-43	
10708480-6	2000	Treatment with the demethylating agent 5-aza-2"-deoxycytidine resulted in activation of the MN/CA9 gene in the negative cell lines (SKRC-12 and -14).	Decitabine	39-61	carbonic anhydrase 9	Homo sapiens	95-98